#10 - GLP-1: A VC’s Personal Experience

from Tech Optimist: An Alumni Ventures Podcast Hosted by Alumni Ventures

In this episode of the Tech Optimist podcast, Grant Demeter (Principal at AV) interviews Mike Collins about his personal experience with Mounjaro. They discuss the drug's impact on Mike's health, the broader implications for the healthcare and investment sectors, and the future potential of GLP-1 treatments. To Learn More: -- Alumni Ventures (AV): www.av.vc -- AV LinkedIn: www.linkedin.com/company/alumniventures -- AV Healthtech Fund: www.av.vc/HealthTech -- Tech Optimist: www.techoptimist.vc Speakers: -- Mike Collins - Host - www.linkedin.com/in/mike-collins-362100 -- Grant Demeter - Guest - www.linkedin.com/in/grant-demeter-a90865116 Chapters: (00:00) - Intro (01:42) - GLP-1 Interview (34:57) - Closing Legal Disclosure: -- https://av-funds.com/tech-optimist-disclosures

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

#10 - GLP-1: A VC’s Personal Experience

0:00 35:52

Chapters

0:00 Intro
1:42 GLP-1 Interview
34:57 Closing

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Frequently asked questions

How long is this episode of Tech Optimist: An Alumni Ventures Podcast?

This episode is 35 minutes long.

When was this Tech Optimist: An Alumni Ventures Podcast episode published?

This episode was published on June 8, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Tech Optimist: An Alumni Ventures Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.